Payment overview · 2025
General Payments
$24.76
1 reported records · 1 companies
Healthcare provider profile · identity verified
Steven Keith Rushing, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · WINONA, MS · NPI 1881600492
Verified facts
What the public records show
CMS Open Payments records show Steven Keith Rushing, M.D. received $24.76 in general payments during 2025 across 1 reported records.
Abbott Laboratories accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $24.76 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $24.76 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $24.76 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 684 | 131 |
| Pantoprazole Sodium | Pantoprazole Sodium | 641 | 110 |
| Levothyroxine Sodium | Levothyroxine Sodium | 524 | 81 |
| Atorvastatin Calcium | Atorvastatin Calcium | 523 | 88 |
| Lisinopril | Lisinopril | 521 | 98 |
| Gabapentin | Gabapentin | 512 | 89 |
| Potassium Chloride | Potassium Chloride | 506 | 90 |
| Metoprolol Succinate | Metoprolol Succinate | 488 | 86 |
| Pravastatin Sodium | Pravastatin Sodium | 486 | 71 |
| Losartan Potassium | Losartan Potassium | 468 | 84 |
| Furosemide | Furosemide | 458 | 75 |
| Eliquis | Apixaban | 406 | 39 |
| Hydrochlorothiazide | Hydrochlorothiazide | 393 | 67 |
| Omeprazole | Omeprazole | 387 | 80 |
| Meloxicam | Meloxicam | 374 | 66 |
| Sertraline Hcl | Sertraline Hcl | 339 | 62 |
| Famotidine | Famotidine | 332 | 51 |
| Metformin Hcl | Metformin Hcl | 302 | 62 |
| Tamsulosin Hcl | Tamsulosin Hcl | 277 | 53 |
| Metoprolol Tartrate | Metoprolol Tartrate | 266 | 40 |
| Donepezil Hcl | Donepezil Hcl | 259 | 29 |
| Mirtazapine | Mirtazapine | 250 | 30 |
| Montelukast Sodium | Montelukast Sodium | 216 | 44 |
| Fluticasone Propionate | Fluticasone Propionate | 211 | 55 |
| Simvastatin | Simvastatin | 208 | 36 |
| Memantine Hcl | Memantine Hcl | 202 | 20 |
| Carvedilol | Carvedilol | 194 | 38 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 182 | 33 |
| Metformin Hcl Er | Metformin Hcl | 163 | 33 |
| Ropinirole Hcl | Ropinirole Hcl | 157 | 26 |
| Divalproex Sodium | Divalproex Sodium | 153 | 16 |
| Quetiapine Fumarate | Quetiapine Fumarate | 150 | 24 |
| Clopidogrel | Clopidogrel Bisulfate | 149 | 28 |
| Citalopram Hbr | Citalopram Hydrobromide | 139 | 22 |
| Buspirone Hcl | Buspirone Hcl | 132 | 14 |
| Amitriptyline Hcl | Amitriptyline Hcl | 129 | 19 |
| Xarelto | Rivaroxaban | 123 | 15 |
| Trazodone Hcl | Trazodone Hcl | 122 | 18 |
| Tramadol Hcl | Tramadol Hcl | 120 | 40 |
| Nifedipine Er | Nifedipine | 118 | 20 |
| Glimepiride | Glimepiride | 108 | 23 |
| Allopurinol | Allopurinol | 98 | 21 |
| Zolpidem Tartrate | Zolpidem Tartrate | 95 | 19 |
| Spironolactone | Spironolactone | 84 | 22 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 83 | 13 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 79 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 78 | suppressed |
| Jardiance | Empagliflozin | 78 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 74 | 18 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 73 | 17 |
| Clonidine Hcl | Clonidine Hcl | 70 | 23 |
| Enalapril Maleate | Enalapril Maleate | 70 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 70 | 14 |
| Levetiracetam | Levetiracetam | 70 | 12 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 69 | 11 |
| Meclizine Hcl | Meclizine Hcl | 68 | 17 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 67 | 15 |
| Warfarin Sodium | Warfarin Sodium | 66 | 17 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 65 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 64 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 60 | 12 |
| Tizanidine Hcl | Tizanidine Hcl | 60 | 12 |
| Ozempic | Semaglutide | 59 | suppressed |
| Finasteride | Finasteride | 58 | 16 |
| Repaglinide | Repaglinide | 58 | suppressed |
| Celecoxib | Celecoxib | 57 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 56 | 18 |
| Benztropine Mesylate | Benztropine Mesylate | 55 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 54 | suppressed |
| Mupirocin | Mupirocin | 54 | 30 |
| Divalproex Sodium Er | Divalproex Sodium | 52 | suppressed |
| Synthroid | Levothyroxine Sodium | 52 | suppressed |
| Atenolol | Atenolol | 51 | suppressed |
| Ezetimibe | Ezetimibe | 51 | 12 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 50 | suppressed |
| Lorazepam | Lorazepam | 50 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 46 | 11 |
| Risperidone | Risperidone | 44 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 44 | suppressed |
| Baclofen | Baclofen | 43 | suppressed |
| Prednisone | Prednisone | 42 | 16 |
| Propranolol Hcl | Propranolol Hcl | 42 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 41 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 41 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 41 | 30 |
| Colchicine | Colchicine | 39 | 14 |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 39 | suppressed |
| Bumetanide | Bumetanide | 38 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 38 | 26 |
| Januvia | Sitagliptin Phosphate | 38 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 38 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 37 | suppressed |
| Febuxostat | Febuxostat | 36 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 36 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 36 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 36 | suppressed |
| Digoxin | Digoxin | 35 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 33 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 33 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 32 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 32 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 32 | suppressed |
| Novolin R Flexpen | Insulin Regular, Human | 31 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 31 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 31 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 30 | 19 |
| Amiodarone Hcl | Amiodarone Hcl | 29 | suppressed |
| Methocarbamol | Methocarbamol | 29 | suppressed |
| Novolin R | Insulin Regular, Human | 29 | suppressed |
| Pregabalin | Pregabalin | 29 | suppressed |
| Irbesartan | Irbesartan | 28 | suppressed |
| Lovastatin | Lovastatin | 28 | suppressed |
| Glipizide Er | Glipizide | 26 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 26 | suppressed |
| Fluconazole | Fluconazole | 25 | 19 |
| Metoclopramide Hcl | Metoclopramide Hcl | 25 | suppressed |
| Novolog Flexpen | Insulin Aspart | 25 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 24 | 12 |
| Estradiol | Estradiol | 24 | suppressed |
| Sucralfate | Sucralfate | 24 | suppressed |
| Valsartan | Valsartan | 24 | suppressed |
| Klor-Con 10 | Potassium Chloride | 23 | suppressed |
| Methimazole | Methimazole | 23 | suppressed |
| Amoxicillin | Amoxicillin | 22 | 17 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 22 | suppressed |
| Movantik | Naloxegol Oxalate | 22 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 21 | suppressed |
| Semglee (Yfgn) Pen | Insulin Glargine-Yfgn | 21 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 21 | 12 |
| Cephalexin | Cephalexin | 20 | 14 |
| Indapamide | Indapamide | 20 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 20 | suppressed |
| Ramipril | Ramipril | 20 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 20 | suppressed |
| Carbamazepine | Carbamazepine | 19 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 19 | suppressed |
| Humulin R | Insulin Regular, Human | 18 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 18 | suppressed |
| Rivastigmine | Rivastigmine | 18 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 18 | suppressed |
| Alprazolam | Alprazolam | 17 | suppressed |
| Cilostazol | Cilostazol | 17 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 17 | 15 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 17 | 12 |
| Glipizide | Glipizide | 17 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 17 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 16 | suppressed |
| Clonazepam | Clonazepam | 16 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 16 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 16 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 16 | suppressed |
| Trulicity | Dulaglutide | 16 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 16 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 15 | suppressed |
| Exelon | Rivastigmine | 15 | suppressed |
| Lansoprazole | Lansoprazole | 15 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 15 | suppressed |
| Gvoke Hypopen 1-Pack | Glucagon | 14 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 14 | suppressed |
| Levofloxacin | Levofloxacin | 14 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 14 | 11 |
| Oxcarbazepine | Oxcarbazepine | 14 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 13 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 13 | suppressed |
| Entresto | Sacubitril/Valsartan | 13 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 13 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Ibuprofen | Ibuprofen | 13 | suppressed |
| Linzess | Linaclotide | 13 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 12 | suppressed |
| Clonidine | Clonidine | 12 | suppressed |
| Eszopiclone | Eszopiclone | 12 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 12 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 12 | suppressed |
| Nystatin | Nystatin | 12 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 12 | suppressed |
| Abilify Maintena | Aripiprazole | 11 | suppressed |
| Chlorthalidone | Chlorthalidone | 11 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 11 | suppressed |
| Diltiazem 24hr Er (Xr) | Diltiazem Hcl | 11 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 11 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 11 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 11 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 11 | suppressed |
| Pentoxifylline | Pentoxifylline | 11 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $24.76 · 1 records | Abbott Laboratories | FREESTYLE LIBRE 3 | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error